PXS Stock Overview
Distributes medical equipment, devices, and consumables to the healthcare markets in Australia, New Zealand, and Asia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Paragon Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.24 |
| 52 Week High | AU$0.27 |
| 52 Week Low | AU$0.22 |
| Beta | 0 |
| 11 Month Change | -8.27% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 10.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| PXS | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -4.7% | 2.8% | 2.8% |
| 1Y | n/a | -2.3% | 4.1% |
Return vs Industry: Insufficient data to determine how PXS performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how PXS performed against the German Market.
Price Volatility
| PXS volatility | |
|---|---|
| PXS Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 3.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: PXS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PXS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 550 | David Collins | paragoncare.com.au |
Paragon Care Limited distributes medical equipment, devices, and consumables to the healthcare markets in Australia, New Zealand, and Asia. It offers its for aesthetics, critical care, diagnostic & scientific, eye care, medical products & consumables, neonatal, orthopaedics service, surgical, technology & connectivity, urology, veterinary products. The company was incorporated in 2005 and is based in Mount Waverley, Australia.
Paragon Care Limited Fundamentals Summary
| PXS fundamental statistics | |
|---|---|
| Market cap | €442.30m |
| Earnings (TTM) | €7.77m |
| Revenue (TTM) | €1.33b |
56.9x
P/E Ratio0.3x
P/S RatioIs PXS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PXS income statement (TTM) | |
|---|---|
| Revenue | AU$2.19b |
| Cost of Revenue | AU$2.06b |
| Gross Profit | AU$131.76m |
| Other Expenses | AU$118.96m |
| Earnings | AU$12.80m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0077 |
| Gross Margin | 6.02% |
| Net Profit Margin | 0.59% |
| Debt/Equity Ratio | 340.9% |
How did PXS perform over the long term?
See historical performance and comparison